These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 19952342)
1. Injection of Urocortin 3 into the ventromedial hypothalamus modulates feeding, blood glucose levels, and hypothalamic POMC gene expression but not the HPA axis. Chen P; Vaughan J; Donaldson C; Vale W; Li C Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E337-45. PubMed ID: 19952342 [TBL] [Abstract][Full Text] [Related]
2. The effect of urocortin I on the hypothalamic ACTH secretagogues and its impact on the hypothalamic-pituitary-adrenal axis. Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G Neuropeptides; 2014 Feb; 48(1):15-20. PubMed ID: 24331779 [TBL] [Abstract][Full Text] [Related]
3. The interaction of Urocortin II and Urocortin III with amygdalar and hypothalamic cotricotropin-releasing factor (CRF)--reflections on the regulation of the hypothalamic-pituitary-adrenal (HPA) axis. Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G Neuropeptides; 2013 Oct; 47(5):333-8. PubMed ID: 23932308 [TBL] [Abstract][Full Text] [Related]
4. Type 2 corticotropin-releasing factor receptor in the ventromedial nucleus of hypothalamus is critical in regulating feeding and lipid metabolism in white adipose tissue. Chao H; Digruccio M; Chen P; Li C Endocrinology; 2012 Jan; 153(1):166-76. PubMed ID: 22067315 [TBL] [Abstract][Full Text] [Related]
5. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system. Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938 [TBL] [Abstract][Full Text] [Related]
6. The effects of the urocortins on the hypothalamic-pituitary-adrenal axis - similarities and discordancies between rats and mice. Bagosi Z; Csabafi K; Karasz G; Jászberényi M; Földesi I; Siska A; Szabó G; Telegdy G Peptides; 2019 Feb; 112():1-13. PubMed ID: 30414887 [TBL] [Abstract][Full Text] [Related]
7. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal. Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179 [TBL] [Abstract][Full Text] [Related]
8. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval. Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404 [TBL] [Abstract][Full Text] [Related]
9. Urocortin in the ventromedial hypothalamic nucleus acts as an inhibitor of feeding behavior in rats. Ohata H; Suzuki K; Oki Y; Shibasaki T Brain Res; 2000 Apr; 861(1):1-7. PubMed ID: 10751559 [TBL] [Abstract][Full Text] [Related]
10. Fetal alcohol exposure alters proopiomelanocortin gene expression and hypothalamic-pituitary-adrenal axis function via increasing MeCP2 expression in the hypothalamus. Gangisetty O; Bekdash R; Maglakelidze G; Sarkar DK PLoS One; 2014; 9(11):e113228. PubMed ID: 25409090 [TBL] [Abstract][Full Text] [Related]
12. Decreased type 2 corticotropin-releasing hormone receptor mRNA expression in the ventromedial hypothalamus during repeated immobilization stress. Makino S; Asaba K; Nishiyama M; Hashimoto K Neuroendocrinology; 1999 Sep; 70(3):160-7. PubMed ID: 10516478 [TBL] [Abstract][Full Text] [Related]
13. Energy state alters regulation of proopiomelanocortin neurons by glutamatergic ventromedial hypothalamus neurons: pre- and postsynaptic mechanisms. Rau AR; Hentges ST J Neurophysiol; 2021 Mar; 125(3):720-730. PubMed ID: 33441043 [TBL] [Abstract][Full Text] [Related]
14. Role of urocortin 2 secreted by the pituitary in the stress-induced suppression of luteinizing hormone secretion in rats. Nemoto T; Iwasaki-Sekino A; Yamauchi N; Shibasaki T Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E567-75. PubMed ID: 20663987 [TBL] [Abstract][Full Text] [Related]
15. The effects of CRF and urocortins on the hippocampal glutamate release. Bagosi Z; Balangó B; Pintér D; Csabafi K; Jászberényi M; Szabó G; Telegdy G Neurochem Int; 2015 Nov; 90():67-71. PubMed ID: 26216727 [TBL] [Abstract][Full Text] [Related]
16. Ventromedial hypothalamic lesions inhibit corticosteroid feedback regulation of basal ACTH during the trough of the circadian rhythm. Suemaru S; Darlington DN; Akana SF; Cascio CS; Dallman MF Neuroendocrinology; 1995 Apr; 61(4):453-63. PubMed ID: 7783859 [TBL] [Abstract][Full Text] [Related]
17. Identification of urocortin 3 afferent projection to the ventromedial nucleus of the hypothalamus in rat brain. Chen P; Lin D; Giesler J; Li C J Comp Neurol; 2011 Jul; 519(10):2023-42. PubMed ID: 21452217 [TBL] [Abstract][Full Text] [Related]
18. Substance P is involved in terminating the hypothalamo- pituitary-adrenal axis response to acute stress through centrally located neurokinin-1 receptors. Jessop DS; Renshaw D; Larsen PJ; Chowdrey HS; Harbuz MS Stress; 2000 May; 3(3):209-20. PubMed ID: 10938582 [TBL] [Abstract][Full Text] [Related]
19. Regulation of the expression and secretion of urocortin 2 in rat pituitary. Nemoto T; Iwasaki-Sekino A; Yamauchi N; Shibasaki T J Endocrinol; 2007 Feb; 192(2):443-52. PubMed ID: 17283244 [TBL] [Abstract][Full Text] [Related]
20. Hypothalamic-pituitary-adrenal activity and pro-opiomelanocortin mRNA levels in the hypothalamus and pituitary of the rat are differentially modulated by acute intermittent morphine with or without water restriction stress. Zhou Y; Spangler R; Maggos CE; Wang XM; Han JS; Ho A; Kreek MJ J Endocrinol; 1999 Nov; 163(2):261-7. PubMed ID: 10556776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]